CRNX
Crinetics Pharmaceuticals, Inc.Company with tickers: CRNX
CIK
1658247
CUSIP
22663K107
Shares Outstanding
105,440,208
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $10,734,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | $200,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $100,081,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-140,378,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-127,845,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-1.23 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-1.23 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |